Bladder Cancer Treatment
Bladder Cancer

Expert Bladder Cancer
Treatment in Faridabad

Comprehensive urothelial carcinoma management with cisplatin-based MVAC/GC chemotherapy, pembrolizumab immunotherapy, and enfortumab vedotin — by Dr. Novak Gupta, Senior Oncologist.

🏥
Sector 88Greater Faridabad
🎓
DM OncologyAdvanced Specialization
🌐
NCCN / ASCOInternational Protocols
💉
Precision MedicineGenomic Profiling
5000+ PatientsSuccessfully Treated
Bladder Cancer Treatment treatment
FGFR3
Targetable in ~20%

What is Bladder Cancer?

Bladder cancer is the most common malignancy of the urinary tract, predominantly arising as urothelial carcinoma (transitional cell carcinoma — TCC) from the urothelial lining. It is classified as non-muscle-invasive (NMIBC — confined to mucosa/submucosa) or muscle-invasive (MIBC — invading the detrusor muscle) bladder cancer, which have dramatically different management. Molecular subtypes (FGFR3, PIK3CA, TP53, ERBB2) are increasingly used to guide targeted therapy. Modern immunotherapy with checkpoint inhibitors has transformed treatment for cisplatin-ineligible and platinum-refractory patients. Haematuria — even a single episode — should always be investigated.

Types: Non-muscle-invasive (NMIBC) vs Muscle-invasive (MIBC) — distinct treatment pathways
Most common subtype: Urothelial carcinoma (TCC) — 90–95% of bladder cancers
FGFR3 mutations: ~15–20% of bladder cancers; erdafitinib (FGFR inhibitor) approved for metastatic disease
First sign: Painless haematuria — the single most important warning sign, never ignore

Symptoms & Early Signs

Early recognition of symptoms leads to timely diagnosis and significantly better treatment outcomes. Do not ignore these warning signs.

🩸

Painless Haematuria

Blood in urine — either visible (gross) or detected on dipstick (microscopic) — is the hallmark symptom of bladder cancer.

🚽

Urinary Frequency & Urgency

Increased urinary frequency, urgency, or burning sensation — common symptoms that mimic urinary tract infection.

😣

Pelvic Pain

Pelvic discomfort or lower back/flank pain — develops as the tumour grows and invades surrounding structures.

🦵

Leg Swelling

Unilateral leg swelling from lymphatic obstruction in advanced pelvic nodal disease.

🚫

Difficulty Urinating

Urinary hesitancy, weak stream, or inability to urinate due to tumour obstructing the urethra or bladder outlet.

📉

Weight Loss & Fatigue

Systemic features of advanced or metastatic bladder cancer — often accompanied by anaemia.

Causes & Risk Factors

Understanding risk factors helps in early detection and prevention. Consult Dr. Gupta if you are at elevated risk.

01
Tobacco Smoking

The single most important risk factor — responsible for ~50% of all bladder cancers; risk is dose-dependent.

02
Occupational Carcinogens

Aromatic amines (rubber, leather, paint, dye industries) and polycyclic aromatic hydrocarbons are bladder carcinogens.

03
Chronic Urinary Tract Infections

Recurrent UTIs and bladder stones cause chronic inflammation linked to squamous cell carcinoma of the bladder.

04
Schistosomiasis

Schistosoma haematobium infection causes squamous cell carcinoma — common in endemic parts of Africa and Middle East.

05
Prior Cyclophosphamide

Cyclophosphamide chemotherapy for prior cancers (lymphoma, breast) is a recognised bladder carcinogen.

06
Aristolochic Acid

Exposure through certain herbal medicines or food contamination is a known cause of urothelial carcinoma.

Risk factors

Haematuria — Never Ignore Blood in Urine

Even a single episode of painless blood in the urine in a person over 40 should trigger urgent urology evaluation including cystoscopy. Early detection of bladder cancer leads to excellent treatment outcomes.

Ready to Take the First Step?

Book a consultation with Dr. Novak Gupta today. Expert oncology care is just a call away.

Book Appointment